Trafalgar International (GCAN) Shares Outstanding (Entity) (2016 - 2026)
Trafalgar International (GCAN) Shares Outstanding (Entity) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 834.66 Mn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 944,935.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,935.00 |
| Dec 31, 2025 | 824,984.00 |
| Sep 30, 2025 | 900,256.00 |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 974.89 Mn |
| Dec 31, 2024 | 804.64 Mn |
| Sep 30, 2024 | 804.64 Mn |
| Jun 30, 2024 | 804.64 Mn |
| Mar 31, 2024 | 804.64 Mn |
| Dec 31, 2023 | 804.64 Mn |
| Sep 30, 2023 | 768.64 Mn |
| Jun 30, 2023 | 732.64 Mn |
| Mar 31, 2023 | 732.64 Mn |
| Dec 31, 2022 | 587.77 Mn |
| Sep 30, 2022 | 668.64 Mn |
| Jun 30, 2022 | 533.64 Mn |
| Mar 31, 2022 | 508.64 Mn |
| Dec 31, 2021 | 508.64 Mn |
| Sep 30, 2021 | 508.64 Mn |
| Jun 30, 2021 | 478.64 Mn |